Natera Inc (NTRA)-医療機器分野:企業M&A・提携分析

◆英語タイトル:Natera Inc (NTRA) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8011280
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月22日
◆ページ数:58
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Natera Inc (Natera), formerly Gene Security Network Inc is a genetic testing and diagnostics company that develops and commercializes non-invasive methods for DNA analysis. The company offers products such as panorama prenatal testing, pre-implantation genetic testing, miscarriage testing, genetic carrier screening and paternity testing. Its pre-implantation genetic testing includes translocation testing, aneuploidy screening, and single gene testing. Natera offers constellation, a cloud-based software product that allows laboratory customers to gain access through the cloud to the company’s algorithms and bioinformatics in order to validate and launch tests. The company also undertakes clinical trial of several genetic materials. Natera is headquartered in San Carlos, California, the US.

Natera Inc (NTRA) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Natera Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
Natera Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 7
Natera Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
Natera Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 9
Natera Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
Natera Inc, Medical Equipment, Deal Details 12
Venture Financing 12
Natera Raises USD55.5 Million in Venture Financing 12
Natera Raises US$54.6 Million In Venture Financing 14
Gene Security Network Secures US$20 Million In Series D Financing 16
Partnerships 17
Natera Enters into Agreement with Imperial College London and University of Leicester 17
Natera Enters into Research Agreement with Aarhus University 18
Natera Enters into Agreement with LifeLabs for Non-Invasive Prenatal Test 19
Diagcor Enters Into Agreement With Natera To Market Panorama NIPT In Hong Kong 20
Natera And Laboratorio Dr. F Echevarne Analisis Enter Into Agreement To Distribute Panorama 21
ARUP Labs Enters Into Co-Marketing Agreement With Natura For Panorama 22
Quest Diagnostics Enters Into Agreement With Natera To Offer Panorama, Non-Invasive Prenatal Screening Test 23
Equity Offering 24
Natera Raises USD180 Million in IPO 24
Natera Inc – Key Competitors 26
Natera Inc – Key Employees 27
Natera Inc – Locations And Subsidiaries 28
Head Office 28
Other Locations & Subsidiaries 28
Recent Developments 29
Strategy And Business Planning 29
Jan 10, 2017: Natera terminates NIPT distribution agreement with Bioreference Labs 29
Financial Announcements 30
Nov 08, 2017: Natera Reports Third Quarter 2017 Financial Results 30
Aug 08, 2017: Natera Reports Second Quarter 2017 Financial Results 32
May 09, 2017: Natera Reports First Quarter 2017 Financial Results 33
Mar 07, 2017: Natera Reports Fourth Quarter and Fiscal Year 2016 Financial Results 35
Nov 09, 2016: Natera Reports Third Quarter 2016 Financial Results 37
Aug 04, 2016: Natera Reports Second Quarter 2016 Financial Results 39
May 10, 2016: Natera Reports First Quarter 2016 Financial Results 41
Mar 08, 2016: Natera Reports Fourth Quarter and Fiscal Year 2015 Financial Results 43
Corporate Communications 45
May 04, 2017: Natera Announces the Appointment of Gail Marcus as Member of the Board of Directors 45
Feb 03, 2017: Natera Announces Appointment of Mike Brophy as New Chief Financial Officer 46
Apr 25, 2016: Natera Announces the Appointment of Kimberly Martin, MD as Senior Global Medical Director, Women’s Health Franchise 47
Legal and Regulatory 48
Jun 30, 2016: Natera Announces that the U.S. Supreme Court Denies Petition to Review ’540 Patent Invalidation 48
Product News 49
Aug 21, 2017: Natera Launches Signatera Personalized Circulating Tumor DNA Technology for Cancer Research 49
Apr 26, 2017: Study in Nature Shows Early Relapse Detection in Lung Cancer Using Natera’s Technology for ctDNA Analysis 50
Dec 14, 2016: Natera Announces Participation In I-SPY 2 TRIAL For Breast Cancer 51
Mar 11, 2016: American Medical Association Grants New CPT Code for Microdeletion Testing 52
Mar 07, 2016: Published Study Demonstrates Natera’s Ability to Identify Heterogeneous Cancer Mutations in Patients with Early-Stage Lung Cancer 53
02/09/2016: Genetica Now Offering PanoramaTM NIPT in Switzerland via Natera’s Constellation Software Platform 54
01/12/2016: Large-Scale Clinical Study Shows Panorama Prenatal Screen to be Highly Accurate in Identifying 22q11.2 Deletion Syndrome in a General Population 55
Other Significant Developments 56
Sep 20, 2017: Natera Selected for Circulating Tumor DNA Study in Bladder Cancer 56
Mar 01, 2017: Natera Announces Launch of Evercord Cord Blood and Tissue Banking Service 57
Appendix 58
Methodology 58
About GlobalData 58
Contact Us 58
Disclaimer 58

List of Tables
Natera Inc, Medical Equipment, Key Facts, 2016 2
Natera Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Natera Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
Natera Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 7
Natera Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
Natera Inc, Deals By Market, 2011 to YTD 2017 9
Natera Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
Natera Raises USD55.5 Million in Venture Financing 12
Natera Raises US$54.6 Million In Venture Financing 14
Gene Security Network Secures US$20 Million In Series D Financing 16
Natera Enters into Agreement with Imperial College London and University of Leicester 17
Natera Enters into Research Agreement with Aarhus University 18
Natera Enters into Agreement with LifeLabs for Non-Invasive Prenatal Test 19
Diagcor Enters Into Agreement With Natera To Market Panorama NIPT In Hong Kong 20
Natera And Laboratorio Dr. F Echevarne Analisis Enter Into Agreement To Distribute Panorama 21
ARUP Labs Enters Into Co-Marketing Agreement With Natura For Panorama 22
Quest Diagnostics Enters Into Agreement With Natera To Offer Panorama, Non-Invasive Prenatal Screening Test 23
Natera Raises USD180 Million in IPO 24
Natera Inc, Key Competitors 26
Natera Inc, Key Employees 27
Natera Inc, Subsidiaries 28

★海外企業調査レポート[Natera Inc (NTRA)-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Sanovas Inc-医療機器分野:企業M&A・提携分析
    Summary Sanovas Inc (Sanovas) focuses on the development of minimally invasive diagnostic and therapeutic technologies and solutions. The company provides imaging technologies, interventional lung, interventional ENT, and interventional uro and gyn products. Its imaging technologies product provides …
  • Gibson Energy Inc (GEI):石油・ガス:M&Aディール及び事業提携情報
    Summary Gibson Energy Inc (Gibson) is an independent midstream energy company. It provides integrated services to the oil and gas industry. The company transport, store, blend, process, market and distribute crude oil, condensate, natural gas liquids, water, oilfield waste, and refined products. Gib …
  • Abdullah Al-Othaim Markets Co.:企業の戦略・SWOT・財務分析
    Abdullah Al-Othaim Markets Co. - Strategy, SWOT and Corporate Finance Report Summary Abdullah Al-Othaim Markets Co. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Pharmaxis Ltd (PXS):製薬・医療:M&Aディール及び事業提携情報
    Summary Pharmaxis Ltd (Pharmaxis) is a pharmaceutical research company that develops and commercialize healthcare products. The company provides products such as aridol which identify twitchy and assist in diagnosing and managing asthma, and bronchitol which restores normal lung hydration, improves …
  • Aurora Health Care Inc:企業の戦略的SWOT分析
    Aurora Health Care Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Tengasco Inc Oil & Gas Exploration and Production Operations and Cost Analysis – Q3, 2017
    Tengasco Inc Oil & Gas Exploration and Production Operations and Cost Analysis - Q3, 2017 Summary Tengasco Inc (Tengasco) is an oil and gas exploration and production company that offers oil and gas development and exploration services. The company acquires, explores, produces, extracts, operates, m …
  • Orsted AS Oil & Gas Exploration and Production Operations and Cost Analysis – Q3, 2017
    Orsted AS Oil & Gas Exploration and Production Operations and Cost Analysis - Q3, 2017 Summary Orsted AS (Orsted) formerly Dong Energy A/S, is an integrated energy company that procures, produces, distributes and trades energy and energy related products. It generates electricity and heat using conv …
  • Evolva Holding SA:企業の戦略・SWOT・財務情報
    Evolva Holding SA - Strategy, SWOT and Corporate Finance Report Summary Evolva Holding SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • ERG SpA (ERG)-エネルギー分野:企業M&A・提携分析
    Summary ERG S.p.A. (ERG), a subsidiary of San Quirico S.P.A., is a diversified energy company. Through its subsidiaries, it conducts power generation through renewable and thermal sources. The company carries out the distribution and marketing of petroleum products and conducts refining activities. …
  • Halozyme Therapeutics Inc (HALO):企業の財務・戦略的SWOT分析
    Halozyme Therapeutics Inc (HALO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • EMIS Group plc (EMIS):企業の財務・戦略的SWOT分析
    Summary EMIS Group Plc (EMIS), formerly Egton Medical Information Systems Ltd, is a provider of information technology and related services. The company provides electronic patient record systems and software solutions such as EMIS web, used for clinical services; EMIS IQ for data extraction; and sy …
  • ResCare Inc:企業の戦略的SWOT分析
    ResCare Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Calgary Scientific Inc:医療機器:M&Aディール及び事業提携情報
    Summary Calgary Scientific Inc (Calgary Scientific) is a medical imaging company that provides research and diagnostic technologies for the medical industry. The company offers ResolutionMD, is a zero-footprint enterprise viewing platform, which is installed in healthcare facilities and used to view …
  • EaglePicher Technologies LLC:企業の戦略的SWOT分析
    EaglePicher Technologies LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • Akari Therapeutics Plc (AKTX):製薬・医療:M&Aディール及び事業提携情報
    Summary Akari Therapeutics Plc (Akari), formerly Celsus Therapeutics Plc is a biopharmaceutical company that develops treatments for rare and orphan autoimmune and inflammatory diseases. The company offers coversin drugs that act on complement component-C5 that helps in preventing the release of C5a …
  • Standard Bank Group Ltd (SBK):電力:M&Aディール及び事業提携情報
    Summary Standard Bank Group Ltd (SBG) is a provider of integrated financial services such as personal and business banking, corporate and investment banking, and wealth management and insurance solutions. The personal and business banking portfolio consists of transactional products, lending product …
  • TSI Holdings Co., Ltd.:企業の戦略・SWOT・財務情報
    TSI Holdings Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary TSI Holdings Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Strayer Education Inc (STRA):企業の財務・戦略的SWOT分析
    Summary Strayer Education Inc (Strayer) operates as an educational service provider that offers undergraduate and graduate degree programs. The institute’s degree programs include business administration, accounting, information technology, education, health services administration and public admini …
  • Medytox Inc (086900):企業の財務・戦略的SWOT分析
    Summary Medytox Inc (Medytox) develops, manufactures and markets biopharmaceutical products. Its products include botulinum toxin type A product, hyaluronic acid filler, medical devices, prescription cream, toxin detection kits and antitoxin therapeutics for treating skin disorders. The company is a …
  • Casey’s General Stores, Inc. (CASY):企業の財務・戦略的SWOT分析
    Casey's General Stores, Inc. (CASY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆